Could a simple stool test revolutionize TB diagnosis for kids and HIV patients?

NCT ID NCT05047315

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study evaluated a new stool-based test (qPCR) to diagnose tuberculosis (TB) in children under 8 and people living with HIV. Researchers in Mozambique, Eswatini, and Uganda tested nearly 2,000 participants to see if the stool test could improve TB detection rates compared to standard methods like sputum tests. The goal is to make TB diagnosis easier and more accessible for those who are often missed.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
stool-based qPCR diagnostic test
What this could lead to
If successful, this could provide a simpler, non-invasive way to diagnose tuberculosis in hard-to-test groups like children and people with HIV, potentially increasing detection rates.
What could go wrong
This is a completed diagnostic accuracy study, not a treatment trial. The test may not be accurate enough in real-world settings, and it does not directly improve health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIAGNOSES DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Baylor Eswatini Clinical Centre of Excellence (COE)

    Mbabane, Eswatini

  • Centro de investigação de Saúde de Manhiça

    Manhiça, Maputo Province, 1929, Mozambique

  • Makerere University

    Kampala, Uganda

More trials for these conditions

Other studies related to the condition(s) this trial covers.